Subscribe
SSKH-Pictures / Shutterstock.com
1 December 2025NewsEuropeMarisa Woutersen

UPC draws hard line on urgency in first SPC dispute

The Paris Local Division says Merz ran out of time to stop Viatris' multiple sclerosis generic, clarifying the court’s urgency standards in the process.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
UPC appeals court hands Amgen a win in cholesterol dispute
27 November 2025   The Court of Appeal has overturned a ruling that revoked the pharma company’s cholesterol-lowering antibody patent, clarifying key principles for assessing inventive step.
Europe
UPC judges call for greater female advocacy at court
27 November 2025   Even when legal teams do include women, the judges say they don’t always see or hear them, emphasising that visibility is critical for aspiring advocates.


Editor's picks

The clinical trial dilemma: Navigating European practice
Big Pharma
The clinical trial dilemma: Navigating European practice
27 November 2025

Editor's picks

Big Pharma
The clinical trial dilemma: Navigating European practice
27 November 2025
Americas
INTA votes in new 2026 president at Florida leadership meeting
20 November 2025
Asia
WIPR Rankings reveals the go-to firms and attorneys for China patent work
7 November 2025
Americas
New AIPLA president calls for greater certainty in US patent law
6 November 2025
Unified Patent Court
Regeneron and CureVac: UPC ‘cannot be ignored’
4 November 2025
Americas
Squires: ‘Inherited patent backlog was an absolute dumpster fire’
1 November 2025

More features

Patent and SPC litigator makes the move from Carpmaels
EU Pharma Package hits the final stretch—but can negotiators agree?
UPC appeals court hands Amgen a win in cholesterol dispute
Squires affirms USPTO’s stance on AI with revised guidance
UPC judges call for greater female advocacy at court
The clinical trial dilemma: Navigating European practice
Novartis counsel on managing patents at a $50bn company
Biotech cleared to make biosimilar of $6bn treatment after landmark ruling